Cargando…
SAT-239 Combination of Immune Check Point Inhibitors Causing Hypopituitarism
Introduction: Immune Check Point inhibitors (ICI) have been associated with immune related adverse events including a wide array of Endocrinopathies particularly when a combination of ICIs is used. We present a case of Hypopituitarism secondary to CTLA-4 inhibitor Iplimumab and PD-1 inhibitor Pembru...
Autores principales: | Dhillon, Puneet, Grover, Harshwant, Slusser, Jonathan, Gopisetti, Neethu, Patel, Tirth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208011/ http://dx.doi.org/10.1210/jendso/bvaa046.1107 |
Ejemplares similares
-
FRI332 Check Point Inhibitor Induced Hypophysitis/Hypopituitarism
por: Chandpuri, Ranjit Singh
Publicado: (2023) -
SAT-236 Unusual Presentation of a Stable Pituitary Macroadenoma with Pituitary Apoplexy Causing SIADH and Pan-hypopituitarism
por: El-Zein, Louna S, et al.
Publicado: (2020) -
SAT346 Empty Sella Syndrome And Hypopituitarism In A Childhood Cancer Survivor
por: Akhter, Wajeeha, et al.
Publicado: (2023) -
SAT-LB58 Molecular Investigation of Recessive Inheritance by Exome Sequencing of Patients With Congenital Hypopituitarism
por: Pereira Ferreira, Nathalia Garcia Bianchi, et al.
Publicado: (2020) -
PMON90 Pituitary Abscess, A rare cause of Hypopituitarism
por: Cordeiro, Monica Fabiola Nogueira, et al.
Publicado: (2022)